Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J is jettisoning two of its promised blockbuster drugs, and it couldn’t come at a worse time
J&J is jettisoning two of its promised blockbuster drugs, and it couldn’t come at a worse time
J&J is jettisoning two of its promised blockbuster drugs, and it couldn’t come at a worse time
Submitted by
admin
on October 17, 2017 - 10:26am
Source:
Endpoints
News Tags:
JNJ
sirukumab
rheumatoid arthritis
talacotuzumab
acute myeloid leukemia
Headline:
J&J is jettisoning two of its promised blockbuster drugs, and it couldn’t come at a worse time
Do Not Allow Advertisers to Use My Personal information
